Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
about
Recent advances in the diagnosis and management of migraineResearch resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in miceCalcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraineTreatment of migraine attacks based on the interaction with the trigemino-cerebrovascular systemCalcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cellsNeuropeptides and their receptors: innovative science providing novel therapeutic targetsActivation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and functionTreatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretionUnderstanding migraine: Potential role of neurogenic inflammationMigraine in the era of precision medicineCGRP as a neuropeptide in migraine: lessons from miceThe 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trialsThe pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraineShedding light on photophobiaThe TRPA1 channel in migraine mechanism and treatmentCurrent Understanding on Pain Mechanism in Migraine and Cluster HeadacheCalcitonin gene-related peptide: physiology and pathophysiologyNeuronal signal substances as biomarkers of migraineRamping it up: RAMP1 and the implications for migraineProinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic classEndosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteriesRole of calcitonin receptor-like receptor in colonic motility and inflammationVariable sensitivity to noxious heat is mediated by differential expression of the CGRP geneCalcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.Migraine pathogenesis and state of pharmacological treatment optionsMigraine: new molecular mechanisms.Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imagingRole of BK(Ca) channels in cephalic vasodilation induced by CGRP, NO and transcranial electrical stimulation in the rat.A reactive oxygen species-mediated component in neurogenic vasodilatation.Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).Treatment of Pediatric Migraine: a Review.Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of MigraineA role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation.Update in new medications for primary care.TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation.Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner
P2860
Q24535949-336F0046-E52C-443D-934A-4AC2B1E0AE4BQ24603724-EEBF3508-FE26-44FB-BE1C-D70650A5C528Q24632671-7908A42D-65CD-4864-BB5C-67CEA548B24FQ24646305-7B9ECFB3-6E31-41D4-B63A-B5849E547644Q24652416-5C7C3D87-3B86-4B39-B8ED-D43FA54F6C88Q24670220-983906C6-0B2A-4105-8E50-0C7743AA1BBCQ24671891-B116DBBC-D290-4B59-8760-65F3ADA5BF45Q24800293-7E02359C-374E-4C98-A91F-8B0A354AA9D1Q26747000-730BFBBB-4EC1-44F2-A6F7-16259B377014Q26748947-197B7CB0-7E13-4A3C-B192-E536CF075BC9Q26821821-95F8094E-477D-47A4-94DB-5142D9053711Q26829564-9E92BECB-5093-4C16-A820-B9032C87AF9FQ27008834-2EEAB09B-7C46-4910-B579-A0EEC7142D7FQ27010343-4045AB7D-C3DF-4174-ADA0-3508176AD244Q27016641-AAC5E505-D5E8-4EBB-B026-15A8D424099AQ28079173-C4C1E473-19E2-4948-ADF2-91122B1DBCC2Q28249298-BC3DCC15-4445-4812-8349-3A90EF89A44EQ28254002-0C372413-EC1C-4BB4-A976-C4BDA1EA7143Q28266882-48E471EA-4F9F-425E-A117-CCD107B0D9C5Q28292548-93F37C12-073F-46A7-9AA3-3F494B8FF234Q28577195-185D85F1-DAB9-4BCD-A06D-6994EAC27181Q28582321-4CC99125-630D-4C50-832C-25ADC8DE2DAEQ28590329-4AB57211-9E88-47DE-BE0D-74DEBE025B8BQ30466408-38E5425D-CD68-49F6-B214-530CA9F9E5D3Q30482553-F7A6F9D6-C888-48D8-8BD7-E97458D5179DQ30496689-E2D434D5-B535-4617-82B1-6F669FDAAA48Q30886663-C91A5FD9-7CEF-46EA-96C2-6DBE670ADD26Q33220839-5F282BDC-A89E-4F75-B4C4-3FAECF66EF80Q33288180-0E59EEA5-6D1F-46A5-8FF7-464A016112B1Q33294924-6FD1C3C2-1A00-4BB0-BF4F-693150C12A6BQ33315296-AB780F75-F92C-412D-90B6-AAEF68313C48Q33516651-CF5E082A-23D9-4456-92B8-3D951142AE12Q33524521-2C32DC9C-F7FD-4695-B06E-1FE7D5A18484Q33572904-EEAB99BB-D415-446D-B5DF-6F3FEC87A22CQ33630515-A200D9D9-1F7B-40E2-BA4A-186E790EC96AQ33730637-CD30D8B9-1CBD-44CF-98B6-9A5372D2D872Q33730845-652609CA-14C2-46DC-8704-2B14204C8742Q33746184-B2F4243B-FD86-4656-A4FB-075D66F51B03Q33778781-CEABACF7-D207-44D6-B4F5-AFB10BBF63E1Q33814709-331BC552-975E-4CAA-AD68-C0112F8DA037
P2860
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@ast
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@en
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@nl
type
label
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@ast
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@en
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@nl
prefLabel
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@ast
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@en
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@nl
P2093
P50
P356
P1476
Calcitonin gene-related peptid ...... e acute treatment of migraine.
@en
P2093
BIBN 4096 BS Clinical Proof of Concept Study Group
David Hall
Ingo W Husstedt
Lynna M Lesko
Stephane Pollentier
Ulrich Meier
P304
P356
10.1056/NEJMOA030505
P407
P577
2004-03-01T00:00:00Z